Transthyretin CA is a progressive disorder and patients ultimately develop heart failure, dysrhythmias, and cardiac conduction disturbances, which result in decreased functional capacity, diminished quality of life, and eventually death.3 The gene discussed is TTR; the disease is heart failure.